Siemens Sponsored Workshop: Early identification and proactive prevention – The impact of diagnostics on patient liver pathways, 

1.30pm – 2pm BST, 10 June 2026 ‐ 30 mins

Industry sponsored workshops

James Dowd, Scientific Marketing Manager, Northwest Europe
The NHS is shifting from treating illness to preventing it, with strong emphasis on obesity, cardiovascular disease, and smoking. Chronic liver disease remains challenging to detect early, as routine tests provide limited insight into fibrosis risk. Using advanced biomarkers, risk‑scoring tools, can improve triage, streamline referrals, and ensure patients receive appropriate care sooner. This approach reduces late‑stage diagnoses and supports better outcomes.
Key takeaways:

• Prevention is now a core NHS priority, with ambitious population‑health targets.
• Advanced liver fibrosis diagnostics and digital tools can strengthen triage and care pathways.
• More efficient referral decisions can reduce late-stage diagnosis and support timely treatment.